HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Sickle cell disease poised for ‘golden age of treatment’ amid progress toward cure
• Will new therapies for sickle cell disease lead to a change or reduction in use of hydroxyurea for the management of pain?
• Timing matters — so do breaks John Sweetenham, MD, FRCP, FACP
• Therapeutic armamentarium in urothelial carcinoma grows with understanding of tumor biology Petros Grivas, MD, PhD
• Low-fat diet reduces risk for breast cancer death among postmenopausal women
• Home recovery program feasible following mastectomy
• Bioimpedance spectroscopy reduces progression of breast cancer-related lymphedema
• Oral contraceptive birth control reduces risk for aggressive ovarian cancer
• Prostate cancer incidence, mortality declines or stabilizes in most countries
• Vitamin D supplementation shows limited benefit in patients with gastrointestinal cancers
• Midostaurin regimen safe, effective in older patients with acute myeloid leukemia
• Sutimlimab induces rapid responses in cold agglutinin disease
• Addition of veliparib to chemotherapy shows modest efficacy in small cell lung cancer
• FDA advisory committee votes on two Daiichi Sankyo cancer therapies
• FDA expands approval of Tibsovo for IDH1-mutant acute myeloid leukemia
• FDA approves Cyramza for hepatocellular carcinoma
• Myeloma specialists join NYU Langone Health’s Center for Blood Cancers
• Breast cancer specialists to lead National Comprehensive Cancer Network board of directors
• UT Southwestern names associate director for clinical affairs
• Association of Community Cancer Centers appoints new president